In Vivo Toxicology Market Expansion Is Reshaping Competitive Dynamics Across The Industry
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
In Vivo Toxicology Market Size, Value And Growth Trends Through 2030
The in vivo toxicology market has experienced substantial growth in recent years. Valued at $5.61 billion in 2025, it is projected to reach $6 billion by 2026, reflecting a compound annual growth rate (CAGR) of 7.0%. This historical expansion was driven by several factors, including a scarcity of standardized animal models, dependence on manual laboratory techniques, heightened pharmaceutical research and development efforts, a rising frequency of chronic disease investigations, and the integration of fundamental imaging and analytical tools.
The in vivo toxicology market is projected to experience robust expansion over the coming years, reaching a valuation of $7.79 billion by 2030 at a compound annual growth rate (CAGR) of 6.7%. This anticipated growth during the forecast period is largely driven by the development of genetically modified organisms tailored for targeted research, the incorporation of automated and high-throughput screening platforms, an increase in CRO outsourcing for toxicology assessments, progress in in vivo imaging and monitoring technologies, and a heightened emphasis on alternative models alongside efforts to reduce animal testing. Among the key trends shaping this period are the growing reliance on rodent and non-human primate models, a rising demand for sophisticated toxicology assay kits and reagents, the broadening of immunotoxicity and genotoxicity testing offerings, the wider adoption of automated liquid handling and imaging systems, and stricter regulatory compliance combined with more robust animal welfare standards.
Download A Free Sample Report For Comprehensive Market Insights:
In Vivo Toxicology Market Growth Momentum: Which Factors Are Influencing Demand?
The rising volume of drug discoveries is anticipated to drive expansion in the in vivo toxicology market moving forward. Drug discovery refers to the scientific process of identifying and designing new compounds that could potentially serve as treatments or preventive measures for various ailments. Advances in biotechnology have significantly accelerated this process by deepening comprehension of disease mechanisms and facilitating the development of more targeted therapies. In vivo toxicology plays a critical role in drug discovery, as it allows for the assessment of safety, tolerability, and possible adverse effects of investigational substances within whole organisms. It aids in detecting dose-limiting toxicities and guides formulation and dosing strategies before clinical trials begin. For example, in November 2024, the Patented Medicine Prices Review Board (PMPRB), a Canadian government agency, reported that over 12,000 new medicines were being tested in clinical trials in 2023, an increase from approximately 9,000 in 2022, with oncology comprising 33% of the pipeline, while infectious and central nervous system diseases accounted for 13% and 12%, respectively. Consequently, the growing number of drug discoveries is fueling the in vivo toxicology market’s growth.
In Vivo Toxicology Market Segment Landscape And Growth Potential
The in vivo toxicology market covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing
3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals
4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications
5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms
Subsegments:
1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents
2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems
In Vivo Toxicology Market Trends Reshaping Industry Growth
Major players in the in vivo toxicology sector are concentrating on creating cutting-edge solutions, including secure cloud-based real-time data platforms, to optimize study management and accelerate decision-making processes. These platforms enable researchers and clients to remotely and securely access toxicology study data, milestones, planning tools, and documents, thereby boosting collaboration and transparency. For example, in March 2023, Charles River Laboratories International Inc., a contract research organization based in the US, unveiled Apollo—a secure cloud-based platform that offers real-time access to toxicology study data. This cloud-based, secure system is tailored to support in vivo general toxicology studies, featuring tools for data visualization, planning, and milestone tracking. It facilitates faster and more informed decisions by delivering real-time access to essential study data. Additionally, the platform streamlines project planning and budget estimation throughout the drug development process. By digitizing toxicology workflows, Apollo improves precision, efficiency, and collaboration in in vivo research.
In Vivo Toxicology Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., Transcure Bioservices Pvt. Ltd.
Access The Complete In Vivo Toxicology Market Report:
In Vivo Toxicology Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the in-vivo toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
